The CHROMED project focuses its investigation on the applicability of an integrated solution for a pathological condition which: a) is very prevalent in ageing patients and b) severely impairs quality of life: COPD with other typical comorbidities such as congestive heart failure and sleep disordered breathing. A specific ICT platform in combination with a set of innovative devices will be used to collect and process useful clinical data at the patient's home and used to optimize their medical treatment. To evaluate the impact of this solution, an international multi-centric randomized control trial will be implemented in five European regions: United Kingdom, Sweden, Estonia, Spain and Slovenia, representing different social and organizational contexts in Europe.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
312
Optimization of patient's treatment according to the data collected by the home monitoring devices
Institute of Clinical Medicine
Tallinn, Estonia
Bolnisnica Sežana Zavod
Sežana, Slovenia
Hospital clinic
Barcelona, Spain
Uppsala University Hospital
Uppsala, Sweden
Lincolnshire Community Health Service
Lincoln, United Kingdom
Aintree University Hospital
Liverpool, United Kingdom
Time to First Hospitalization
It represents the number of days, since the enrolment into the study, to the first hospitalization
Time frame: From enrolment up to 9 months
Final Utility Index of EQ-5D Questionnaire
The quality of life of patients as quantified by the final utility index of the EQ-5D questionnaire. The utility index ranges from -0.074 to 1 with 1 being the highest possible quality of life.
Time frame: 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.